NCT07746518 — "A Phase III Clinical Trial and Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis" trial site landscape

Public-registry site landscape for NCT07746518, “A Phase III Clinical Trial and Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis”, a Healed Erosive Esophagitis study sponsored by Daewoong Pharmaceutical Co. LTD.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07746518 (registry record)
Study title	A Phase III Clinical Trial and Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis
Official title	A Multi-center, Double-blind, Randomized, Active-controlled, Parallel-group, Phase III Clinical Trial and Open-label Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis
Sponsor	Daewoong Pharmaceutical Co. LTD.
Condition(s)	Healed Erosive Esophagitis
Phase	PHASE3
Listed sites	0

Patient-friendly overview of this study: eichor.com/study/NCT07746518.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07746518 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →